Literature DB >> 33654805

Gentamicin Protection Assay to Determine the Number of Intracellular Bacteria during Infection of Human TC7 Intestinal Epithelial Cells by Shigella flexneri.

Atin Sharma1,2,3, Andrea Puhar1,2,3.   

Abstract

Shigella flexneri is an intracellular bacterial pathogen that gains access to the gut epithelium using a specialized Type III Secretion System (T3SS). Various determinants mediating this invasive infection have been experimentally verified using the classical gentamicin protection assay presented here. In this assay epithelial cell lines are infected by bacteria in vitro and the extracellular bacteria are killed by gentamicin. The internalized bacteria, which are protected from the bactericidal action of gentamicin, are recovered by lysing the epithelial cells and enumerated by determining the colonies formed on solid medium. Various techniques based on light microscopy, such as immunofluorescence and bacteria expressing fluorescent proteins, are also used for studying intracellular bacteria. However, these techniques are not only labor intensive and require sophisticated equipment, but mostly are also not quantitative. Despite being an easy quantitative method to study invasiveness of bacteria, the gentamicin protection assay cannot distinguish between the survival and multiplication of the internalized bacteria over longer incubation periods. To alleviate the complications created by multiplication and dissemination of internalized bacteria, complementary assays like plaque formation assays are required. This protocol presents an easy and cost-effective method to determine the invasiveness and the capacity to establish an infection of Shigella under different conditions.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Intestinal epithelial cells; Intracellular pathogen; Invasion; Shigella; Type III Secretion System

Year:  2019        PMID: 33654805      PMCID: PMC7854172          DOI: 10.21769/BioProtoc.3292

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  5 in total

1.  Type III secretion system.

Authors:  Andrea Puhar; Philippe J Sansonetti
Journal:  Curr Biol       Date:  2014-09-08       Impact factor: 10.834

2.  A Shigella effector dampens inflammation by regulating epithelial release of danger signal ATP through production of the lipid mediator PtdIns5P.

Authors:  Andrea Puhar; Hélène Tronchère; Bernard Payrastre; Guy Tran Van Nhieu; Philippe J Sansonetti
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

3.  Involvement of a plasmid in the invasive ability of Shigella flexneri.

Authors:  P J Sansonetti; D J Kopecko; S B Formal
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

4.  Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation.

Authors:  I Chantret; A Rodolosse; A Barbat; E Dussaulx; E Brot-Laroche; A Zweibaum; M Rousset
Journal:  J Cell Sci       Date:  1994-01       Impact factor: 5.285

Review 5.  Shigella manipulates host immune responses by delivering effector proteins with specific roles.

Authors:  Hiroshi Ashida; Hitomi Mimuro; Chihiro Sasakawa
Journal:  Front Immunol       Date:  2015-05-07       Impact factor: 7.561

  5 in total
  2 in total

1.  Strongylocentrotus nudus Eggs Polysaccharide Enhances Macrophage Phagocytosis Against E.coli Infection by TLR4/STAT3 Axis.

Authors:  Xinlei Tian; Min Guo; Xiaoya Zhang; Lingfeng Guo; Nan Lan; Yaojun Cheng; Yannan Han; Mingxin Wang; Zhonglu Peng; Changlin Zhou; Hongye Fan
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

2.  High prevalence of small intestine bacteria overgrowth and asymptomatic carriage of enteric pathogens in stunted children in Antananarivo, Madagascar.

Authors:  Jean-Marc Collard; Lova Andrianonimiadana; Azimdine Habib; Maheninasy Rakotondrainipiana; Prisca Andriantsalama; Ravaka Randriamparany; M A N Rabenandrasana; François-Xavier Weill; Nathalie Sauvonnet; Rindra Vatosoa Randremanana; Vincent Guillemot; Pascale Vonaesch; Philippe J Sansonetti
Journal:  PLoS Negl Trop Dis       Date:  2022-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.